Researchers from Inserm and physicians from the Department of Paediatric Endocrinology, Gynaecology and Diabetology at Necker Hospital for Sick Children (AP-HP, Inserm U1016, Paris Descartes University, Imagine Institute) have developed an improved treatment for a rare form of early childhood diabetes associated with cognitive disorders. Their work, conducted in collaboration with the Neurophysiology Department of Pitié-Salpêtrière Hospital, AP-HP, shows that a drug used for decades to treat type 2...
A Cerebrovascular Accident results from the interruption of blood flow to the brain. The deprivation of oxygen and essential nutrients causes brain cells to die, leading to permanent damage (speech or writing difficulty, memory problems, bodily paralysis to a greater or lesser extent), or even sudden death.
Each year, obesity kills 2.8 million people worldwide. When confronting morbid overweight—and its direct consequence, type 2 diabetes—surgery is used as a last resort. Strangely, in patients who have had such an operation, the diabetes disappears before and independently of weight loss. Inserm researchers, with the help of physicians from Bichat Hospital, AP-HP, have shown that the surgically reconfigured intestine might be at the root of this improved glycaemic...
Inserm is paying close attention to the level 2 incident, declared on 21 October 2015 by the French Nuclear Safety Authority (ASN), which occurred in a joint Inserm/University of Bordeaux laboratory.
In 2012, the Île-de-France Regional Health Agency initiated a regional project aimed at Reducing Infant and Perinatal Mortality (RéMI). This initiative was primarily focused on Seine-Saint-Denis, a district characterised by excess infant mortality (death before one year of age) and perinatal mortality (foetal deaths and deaths in the first week of life).
The team led by Didier Leys and Régis Bordet (UMR-S 1171, Lille 2 University, Inserm, Lille University Hospital) has identified a biomarker that makes it possible to predict the risk of haemorrhagic complications from thrombolytic treatment following a Cerebrovascular Accident (CVA or stroke).
Monday 12 October saw the start of the annual vaccination campaign, which will continue until the end of January 2016
Thanks to work done at Institute Curie by a team led by Fatima Mechta-Grigoriou, Inserm Research Director, it is now possible to identify, among women with aggressive ovarian cancer, those who could benefit from a promising targeted therapy.
On 12 October 2015, World Arthritis Day, a Research and Information Day, “Together against Arthritis” will be held at Espace Charenton, Paris, under the patronage of Mr François Hollande, President of France.
Announced at the end of 2014 during the final phase of research and development, the rapid diagnostic test for Ebola virus disease developed by the French Atomic Energy Commission (CEA), with support from the Inserm Jean Mérieux P4 high-level biological containment laboratory (Lyon), has been assessed in the field, including in Guinea, over a period of several months.
Inserm is pleased to have awarded its 2008 International Prize to Tomas Lindahl, who was today awarded the 2015 Nobel Prize in Chemistry.
